📰 All News
Life Science & Pharma News
The latest pharmaceutical, biotechnology, MedTech, and healthcare news and analysis from Ireland, the EU, and globally.
224
Articles
19
Pages
IE
Ireland first
Industry
Ireland Reconsiders Nuclear Energy Ban as Data Center Power Demand Surges
Amid surging electricity consumption from data centers, which now account for 23% of Ireland's grid usage, the Irish government is debating the repeal of its 1999 nuclear power ban.
Industry
Expert Tips for Launching Pharmaceutical Products in Europe: A Market Access Handbook
Securing market entry in Europe requires navigating the centralized EMA regulatory approval and country-specific pricing and reimbursement frameworks. This handbook outlines key steps under the new EU HTAR.
Industry
Boston Scientific Cybersecurity Incident Disrupts Global Shipping and Order Processing
A cybersecurity incident detected at Boston Scientific on August 25, 2026, has caused a network outage impacting global IT systems and customer order fulfillment, highlighting the sector's vulnerability.
Industry
Unpacking Anthropic's 100-Day Sprint to Reshape Biopharma and Drug Discovery
In a rapid mid-2026 expansion, Anthropic has launched Claude Science, acquired Coefficient Bio, appointed Novartis CEO Vas Narasimhan to its board, and secured a landmark enterprise deal with Bristol Myers Squibb.
Industry
FedEx Launches Dedicated Life Sciences Division to Secure Global Pharmaceutical Logistics
FedEx has consolidated its healthcare logistics capabilities into FedEx Life Sciences, a dedicated business unit led by Nick Gennari that leverages global cold chain centers and real-time monitoring to secure temperature-sensitive pharmaceutical supply chains.
Industry
Piramal Pharma Acquires Majority Stake in Hyderabad CDMO Yapan Bio
Piramal Pharma Solutions has completed the acquisition of an additional 40.67% equity stake in Hyderabad-based Yapan Bio for ₹76 crore, raising its total stake to 74% and integrating Yapan's biologics and gene therapy manufacturing capabilities.
Industry
WuXi Biologics Accelerates Global Biomanufacturing Timelines Through Single-Use Technology and Advanced Platforms
WuXi Biologics CEO Dr. Chris Chen outlines the company's integrated CRDMO model and the role of proprietary platforms like WuXia TrueSite, WuXiUI, and PatroLab in reducing biopharma development timelines and scaling single-use manufacturing.
Industry
Phoenix Equity Partners Invests 70 Million Euros in Medmark to Scale Occupational Healthcare Across Ireland
UK-based private equity firm Phoenix Equity Partners has announced a strategic investment of approximately 70 million euros in Medmark, Ireland's largest occupational healthcare provider, to fund digital health platforms and regional acquisitions.
Industry
SK pharmteco Completes Dual Facility Expansion at Swords Campus in Ireland
SK pharmteco has finalized a major manufacturing expansion at its Swords site in Co. Dublin, Ireland. The project adds a multipurpose GMP small-molecule API facility and a kilo-scale GMP HPAPI and ADC payload facility to scale potent therapies from development to commercial supply.
Pharmaceutical
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma
Irish cannabinoid manufacturer Dunbar Pharma has partnered with IPS Pharma to introduce its EU GMP-certified, plant-derived Dronabinol API, WaterClear THC™, to patients across the United Kingdom.
Industry
Dixon Technologies Secures 220 Million USD Corporate Guarantee for Lenovo Ireland IT Hardware Manufacturing
Dixon Technologies has issued an irrevocable corporate guarantee of 220 million USD on behalf of its subsidiary Padget Electronics in favor of Lenovo Ireland to secure IT hardware component procurement.
Industry
TMC Pharma Services Acquires tranScrip to Expand Global Life Science Regulatory and Medical Consulting Capabilities
TMC Pharma Services has acquired contract drug development organization tranScrip, combining clinical trial execution and contract research with deep regulatory affairs, medical, and scientific advisory services.